Kobayashi Pharmaceutical Co., Ltd.

KBYPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$50,873$71,536$96,233$95,024
Short-Term Investments$14,872$8,300$8,300$14,022
Receivables$49,442$52,984$47,853$55,147
Inventory$24,163$22,081$17,678$15,107
Other Curr. Assets$5,118$3,430$2,828$2,589
Total Curr. Assets$144,468$158,331$172,892$181,889
Property Plant & Equip (Net)$67,448$47,665$34,778$22,524
Goodwill$9,260$9,655$7,147$7,189
Intangibles$11,414$11,959$6,160$5,469
Long-Term Investments$9,745$23,824$20,209$15,444
Tax Assets$3,087$2,647$1,750$1,489
Other NC Assets$19,943$13,389$12,888$18,547
Total NC Assets$120,897$109,139$82,932$70,662
Other Assets$3$3$3$3
Total Assets$265,368$267,473$255,827$252,554
Liabilities
Payables$8,264$17,305$18,056$17,444
Short-Term Debt$343$379$261$170
Tax Payable$2,259$4,847$4,908$4,475
Deferred Revenue$0$32,589$27,870$28,148
Other Curr. Liab.$35,557$991$714$466
Total Curr. Liab.$46,423$56,111$51,809$50,703
LT Debt$503$608$531$460
Deferred Rev, NC$0$939$2,034$2,019
Deferred Tax Liab, NC$1,554$0$1,310$1,564
Other NC Liab.$3,418$4,999$3,554$3,773
Total NC Liab.$5,475$6,546$6,119$6,252
Other Liabilities$0$0$0$0
Cap. Leases$846$987$792$629
Total Liabilities$51,898$62,657$57,928$56,955
Equity
Pref Stock$0$0$0$0
Common Stock$3,450$3,450$3,450$3,450
Retained Earnings$208,240$205,681$194,285$200,534
AOCI$26,021$19,929$14,124$11,138
Other Equity-$24,245-$24,244-$13,960-$19,523
Total Equity$213,466$204,816$197,899$195,599
Supplemental Information
Minority Interest$4$0$0$0
Total Liab. & Tot. Equity$265,368$267,473$255,827$252,554
Net Debt-$50,027-$70,549-$95,441-$94,394